Nigerian Public Alert 52: NAFDAC Notifies on Mop-up of Counterfeit Dermazin (1% Silver Sulphadiazine) Cream

Nigerian Public Alert 52: The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting healthcare providers and the public about the circulation of counterfeit Dermazin (1% Silver Sulphadiazine) Cream.

NAFDAC received a complaint from the legitimate Marketing Authorization Holder, Taylek Drugs Company Limited, concerning the sale of this counterfeit product. The packaging of the falsified Dermazin Cream falsely claims that it is produced by Taylek Drugs Company Limited.

Risk Statement

The illegal marketing of medicinal products and counterfeit medicines is a significant health risk as it fails to ensure the safety, quality, and efficacy of these items, violating regulatory standards.

Product details

The details of the counterfeit products are as follows:

Product Details Original Counterfeit
Product Name Dermazin (1% Silver Sulphadiazine) Cream Dermazin (1% Silver Sulphadiazine) Cream
Stated Manufacturer Taylek Drugs Company Limited Taylek Drugs Company Limited
Batch Number PF6565 MV5093
Manufacturing Date 11/2024 05/2024
Expiry Date 10/2027 05/2027

All NAFDAC zonal directors and state coordinators have been instructed to conduct surveillance and remove the counterfeited product if found within their zones and states.

Distributors, retailers, healthcare professionals, and caregivers are hereby advised to exercise caution and vigilance within the supply chain to avoid the distribution, sale, and use of counterfeit products. All medical products must be purchased from authorized or licensed suppliers. The products’ authenticity and physical condition should be carefully checked.

Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call NAFDAC on 0800-162-3322, or via email: sf.alert@nafdac.gov.ng

Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng , or via the Med- safety application available for download on Android and IOS stores, or via e-mail on pharmacovigilance@nafdac.gov.ng

 

PositiveNaija Nigerian Public Alert

The Nigerian Public Alert 52 initiative by PositiveNaija is aimed at keeping Nigerians well-informed particularly in regards to their safety and development. For future developments on this news, kindly follow up through the official communication channels of the reporting/regulatory authority.

We publish these alerts for free and will appreciate your support for our work – Moniepoint – 9064503292 – United Green Stars Worldwide Limited (kindly describe as “donation or gift”). Thank you.

Subscribe
Notify of
guest

0 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments